Reblozyl (luspatercept)

pCPA File Number: 21686
Negotiation Status:
Concluded with an LOI
Indication(s):
Myelodysplastic Syndromes Associated Anemia
Sponsor/Manufacturer:
Celgene Inc.
CDA-AMC Project Number:
SR0670-000
pCPA Engagement Letter Issued:
Negotiation Process Concluded: